Evidence-based medicine in the treatment of non-small-cell lung cancer.
作者： Michael S. Reif , Mark A. Socinski , M. Patricia Rivera
DOI: 10.1016/S0272-5231(05)70011-3
关键词: Radiation therapy 、 Oncology 、 Lung cancer 、 Disease 、 Respiratory disease 、 Survival rate 、 Chemotherapy 、 Evidence-based medicine 、 Surgery 、 Internal medicine 、 Carcinoma 、 Medicine
摘要: Treatment decisions for non-small-cell lung cancer require accurate initial staging of patients. Typically surgical resection is recommended early stage disease, while chemotherapy in conjunction with radiotherapy and possibly selected patients locally advanced disease. Chemotherapy clearly has been demonstrated to improve survival quality life metastatic Surgical, chemotherapeutic, treatment options as well the role multi-modality therapy will be discussed focusing on evidence various stages cancer.
sci-hub.se 参考文章(75)
F.G. Pearson, N.C. DeLarue, R. lives, T.R.J. Todd, J.D. Cooper, Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 83, pp. 1- 11 ,(1982) , 10.1016/S0022-5223(19)37318-0
Nael Martini, Betty J. Flehinger, Fumio Nagasaki, Bonny Hart, Prognostic significance of N1 disease in carcinoma of the lung. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 86, pp. 646- 653 ,(1983) , 10.1016/S0022-5223(19)39079-8
E. Carmack Holmes, Treatment of stage II lung cancer (T1N1 and T2N1). Surgical Clinics of North America. ,vol. 67, pp. 945- 949 ,(1987) , 10.1016/S0039-6109(16)44332-X
Robert J. Ginsberg, Lucius D. Hill, Robert T. Eagan, Paul Thomas, Clifton F. Mountain, Jean Deslauriers, Willard A. Fry, Ralph O. Butz, Melvyn Goldberg, Paul F. Waters, Donald P. Jones, Peter Pairolero, Lawrence Rubinstein, F. Griffith Pearson, Modern thirty-day operative mortality for surgical resections in lung cancer. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 86, pp. 654- 658 ,(1983) , 10.1016/S0022-5223(19)39080-4
Robert J. Jensik, L. Penfield Faber, Frank J. Milloy, David O. Monson, Segmental resection for lung cancer: A fifteen-year experience The Journal of Thoracic and Cardiovascular Surgery. ,vol. 66, pp. 563- 572 ,(1973) , 10.1016/S0022-5223(19)40590-4
William H. Warren, L. Penfield Faber, Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: Five-year survival and patterns of intrathoracic recurrence The Journal of Thoracic and Cardiovascular Surgery. ,vol. 107, pp. 1087- 1094 ,(1994) , 10.1016/S0022-5223(12)70385-9
David E. Williams, Peter C. Pairolero, Charles S. Davis, Philip E. Bernatz, W. Spencer Payne, William F. Taylor, Mary A. Uhlenhopp, Robert S. Fontana, Survival of patients surgically treated for Stage I lung cancer The Journal of Thoracic and Cardiovascular Surgery. ,vol. 82, pp. 70- 76 ,(1981) , 10.1016/S0022-5223(19)39389-4
H M Golomb, R R Blough, P C Hoffman, C Skosey, M K Ferguson, A G Little, D B Skinner, T R DeMeester, Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery. ,vol. 100, pp. 621- 628 ,(1986)
RJ Stephens, , DJ Girling, NM Bleehen, K Moghissi, HMA Yosef, D Machin, The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. British Journal of Cancer. ,vol. 74, pp. 632- 639 ,(1996) , 10.1038/BJC.1996.413
K S Albain, V W Rusch, J J Crowley, T W Rice, A T Turrisi, J K Weick, V A Lonchyna, C A Presant, R J McKenna, D R Gandara, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Journal of Clinical Oncology. ,vol. 13, pp. 1880- 1892 ,(1995) , 10.1200/JCO.1995.13.8.1880